Rossari Biotech Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 15x vs industry 37x)
- Low debt relative to equity (D/E 0.3x)
- Near 52-week low — potential value zone (₹373)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SOLARINDS Solar Industries India Limited | ₹19,240 | ₹1.7L Cr | 83.4 | 27.72 | 32.6 | 38.1 | 0.17 |
| PIDILITIND Pidilite Industries Limited | ₹1,390 | ₹1.5L Cr | 57.2 | 13.11 | 23.9 | 31 | 0.05 |
| SRF SRF Limited | ₹2,350 | ₹68K Cr | 29 | 4.55 | 14.3 | 14.6 | 0.35 |
| COROMANDEL Coromandel International Limited | ₹— | ₹51K Cr | 27.1 | 4.12 | 16.4 | 22 | 0.11 |
| LINDEINDIA Linde India Limited | ₹— | ₹49K Cr | 89.3 | 15.49 | 13.6 | 18.2 | 0.02 |
| FLUOROCHEM Gujarat Fluorochemicals Limited | ₹— | ₹47K Cr | 75.3 | 5.25 | 7.82 | 9.64 | 0.29 |
| FACT Fertilizers and Chemicals Travancore Limited | ₹— | ₹43K Cr | 2,930 | 41 | 1.61 | 8.65 | 2.79 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ROSSARI · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 68.34% | 68.32% | 68.32% | 68.27% | 68.19% | 68.18% |
| FII | 4.14% | 4.02% | 3.83% | 3.74% | 3.74% | 3.98% |
| DII | 18.06% | 17.74% | 16.87% | 17.34% | 17.47% | 17.59% |
| Public | 9.45% | 9.90% | 10.98% | 10.64% | 10.60% | 10.24% |
Latest News
All newsRossari Biotech announces Q2 FY27 results release
*Rossari Biotech announces Q2 FY27 results release.* The company has informed the exchange about the upcoming disclosure of its financial performance for the second quarter of FY27. Traders will focus on **revenue growth**, **profit margins**, and **guidance** for near-term outlook. Key metrics may influence short-term price action. 📊 *STOCKS:* $ROSSARI | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings
Rossari Biotech shares unchanged after investor presentation.
Rossari Biotech held an investor presentation, sharing business updates and strategic outlook. No major financial announcements or guidance changes were disclosed. The stock remained flat post-event as market awaited concrete developments. 📊 *STOCKS:* ROSSARI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorPresentation
Rossari Biotech to hold investor meet
*Rossari Biotech to hold investor meet.* The company has informed about an upcoming Analyst and Institutional Investor Meet or Conference Call. Purpose is to share business updates with the investment community. No financial figures or strategic shifts disclosed. 📊 *STOCKS:* $ROSSARI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
5 stocks added to MSCI India Standard Index
*5 stocks added to MSCI India Standard Index*. MSCI’s February index review added Dixon, JK Cement, Precision Camshafts, Gland Pharma, and Rossari Biotech. Inclusion may attract passive foreign inflows into these stocks. Index rebalancing impacts global fund tracking MSCI benchmarks. 📊 *STOCKS:* DIXON, JKCEMENT, PRECAM, GLAND, ROSSARI | 🏢 *SECTOR:* Indices | #MEDIUMIMPACT #MSCI